Economy · Full coverage
More layoffs possible? After Ramat Hovav, Teva's Kfar Saba plant is in the crosshairs
How 5 Israeli newsrooms covered this story — translated into English and compared side by side.
50% centerFirst reported by TheMarker · Jun 10, 2026
Center 1Right 1Unrated 3
What happened
Teva employees in Kfar Saba fear hundreds of additional layoffs after the company cut 250 jobs at its Ramat Hovav site. A source close to Teva said management may move generic tablet production abroad, while the sterile segment would remain in Kfar Saba. The report also says Trima in Ma'abarot is set to close and Katzat may be sold to Dexel.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 5 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
600 Workers to Lose Jobs as Nahariya Blade-Technology Plant ClosesJun 16, 2026Teva Finance Chief Sells Nearly NIS 62 Million in Shares as Stock SurgesJun 16, 2026Snyk cuts dozens of jobs in Israel in fourth layoff round2 days agoTel Aviv stocks fall 1% as insurance and cleantech shares weigh; Teva gains 4.2%Jun 10, 2026Despite Turkey's Boycott, Some Israeli Companies Keep Trading There4 days agoeToro Executive Warns of 25% to 30% Tech Layoffs Within a YearJun 17, 2026
